NewsDetail
Hamad Medical Corporation’s (HMC) committee for blood transfusion announced a new program that monitors blood transfer procedures in the country. The Centralized Hemovigilance Program improves the quality of the blood transfusion chain, primarily focusing on safety.
Dr. Aisha Ibrahim Al Malki, Assistant Executive Director of Medical Services and Chair of the Blood Transfusion Committee and Centralized Haemovigilance Program said: “This program is the first of its kind in Qatar and the Arab region and aims to improve the blood transfusion system by providing an extra level of safety for donors and recipients. It improves the quality of the blood transfusion chain, primarily focusing on safety.”
A blood transfusion chain is a system for storing and transporting blood and blood products from the point of collection from a blood donor to the point of transfusion to a patient.
The new program improves the overall quality of the collection, storage, testing and distribution of blood and its components, reporting any complications or errors in blood transfer.
Dr. Al Malki said the program will be initially implemented at HMC and then it will be widely introduced across all healthcare facilities in Qatar that collect, use or store blood and blood components.
Earlier this month, 20 members of HMC’s Quality, Nursing, and Emergency Departments, along with staff from the Blood Donor Unit and Blood Transfer Center attended an education session about the new program.
